Deferasirox 45963-0456
Product NDC
45963-0456- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 22, 2019
- Application
- ANDA203560
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 500 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(1)
30 TABLET, FOR SUSPENSION in 1 BOTTLE (45963-456-30)